A review examines how TARDBP splicing may relate to ALS and FTD
Original source
Splicing the narrative: alternative TARDBP splicing and its relation to neurodegeneration in ALS and FTD. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Study type
- Review
- Studied in
- Human, Animal
A review examines how alternative splicing of TARDBP, the gene that encodes TDP-43, produces different RNA and protein forms. It brings together evidence about how these forms may affect the biology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Why this matters
The review may help researchers identify questions about TDP-43 biology and disease mechanisms. It does not demonstrate a new treatment or change clinical care for people living with ALS or FTD.
Limitations and context
This is a review of existing evidence, not a new clinical trial or treatment study. It highlights unresolved questions, so the role of alternative TARDBP splicing in disease remains to be established.
Relevant to you?